China Biotech Services Holdings Limited (HKG:8037)

HKG:8037 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	47.15	12.08	18.91	72.09	92.77	150.55
Trading Asset Securities	-	-	-	-	-	1.76
Cash & Short-Term Investments	47.15	12.08	18.91	72.09	92.77	152.31
Cash Growth	317.60%	-36.11%	-73.76%	-22.30%	-39.09%	-60.52%
Accounts Receivable	1.86	5.62	7.03	19.76	751.9	92.13
Other Receivables	25.64	7.16	14.09	25.23	1.84	4.24
Receivables	27.51	12.78	21.13	45	761.37	109.63
Inventory	56.35	36.94	3.97	9.27	18.73	4.74
Prepaid Expenses	5.76	10.75	1.99	-	4.75	1.57
Restricted Cash	0.01	0.01	0.01	-	0	2.14
Other Current Assets	20.28	7.12	17.08	134.81	7.14	7.38
Total Current Assets	157.05	79.69	63.1	261.17	884.76	277.77
Property, Plant & Equipment	436.25	401.94	235.34	124.22	128.86	105.49
Long-Term Investments	29.08	30.66	43.23	56.92	99.16	122.02
Goodwill	112.51	108.84	103.89	107.18	110.08	120.55
Other Intangible Assets	31.7	31.77	34.94	57.64	67.31	80.94
Other Long-Term Assets	48.3	49.68	49.46	55.24	180.32	-
Total Assets	814.89	702.58	529.96	662.36	1,470	706.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	9.9	33.7	7.35	5.79	206.44	16.15
Accrued Expenses	6.28	27.39	20.35	23.1	77.16	28.19
Short-Term Debt	-	-	138.69	30.96	5.64	17.39
Current Portion of Long-Term Debt	118.56	240.2	-	53.88	-	38.65
Current Portion of Leases	3.16	6.96	5.71	9.83	10.98	7.58
Current Income Taxes Payable	0.4	0.4	0.12	3.73	242	85.2
Other Current Liabilities	34.87	37.11	20.39	32.18	6.44	34.25
Total Current Liabilities	173.17	345.76	192.61	159.47	548.66	227.4
Long-Term Debt	339.17	142.08	41.64	-	55.8	-
Long-Term Leases	0.99	5.66	1.79	5.73	9.37	3.56
Long-Term Deferred Tax Liabilities	3.56	4.05	5.04	6.44	7.89	9.94
Other Long-Term Liabilities	109.71	49.28	46.48	-	22.25	-
Total Liabilities	626.59	546.83	287.57	171.64	643.97	240.89

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	97.57	97.57	97.57	96.32	96.32	96.32
Additional Paid-In Capital	-	494.18	494.18	490.69	490.69	490.69
Retained Earnings	-	-603.25	-534.47	-310.8	-209.91	-475.13
Comprehensive Income & Other	118.78	202.9	207.65	186.54	225.57	283.52
Total Common Equity	216.36	191.41	264.94	462.75	602.68	395.4
Minority Interest	-28.06	-35.67	-22.55	27.97	223.85	70.5
Shareholders' Equity	188.3	155.75	242.39	490.73	826.52	465.9
Total Liabilities & Equity	814.89	702.58	529.96	662.36	1,470	706.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	461.88	394.9	187.83	100.4	81.78	67.17
Net Cash (Debt)	-414.74	-382.82	-168.92	-28.31	10.99	85.14
Net Cash Growth	-	-	-	-	-87.10%	-69.53%
Net Cash Per Share	-0.43	-0.39	-0.17	-0.03	0.01	0.09
Filing Date Shares Outstanding	975.73	975.73	975.73	963.23	963.23	963.23
Total Common Shares Outstanding	975.73	975.73	975.73	963.23	963.23	963.23
Working Capital	-16.12	-266.07	-129.52	101.7	336.09	50.38
Book Value Per Share	0.22	0.20	0.27	0.48	0.63	0.41
Tangible Book Value	72.14	50.81	126.1	297.93	425.28	193.91
Tangible Book Value Per Share	0.07	0.05	0.13	0.31	0.44	0.20
Land	-	15.21	15.21	15.21	15.21	15.21
Machinery	-	30.31	24.66	177.31	183.07	155.86
Construction In Progress	-	419.84	255.18	63.64	5.88	-
Leasehold Improvements	-	9.97	11	15.3	16.77	12.16

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error